4/19
04:33 am
crsp
Is Vertex Pharmaceuticals Stock a Millionaire Maker? [Yahoo! Finance]
Low
Report
Is Vertex Pharmaceuticals Stock a Millionaire Maker? [Yahoo! Finance]
4/18
01:18 pm
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target raised by analysts at Citigroup Inc. from $88.00 to $89.00. They now have a "buy" rating on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target raised by analysts at Citigroup Inc. from $88.00 to $89.00. They now have a "buy" rating on the stock.
4/17
01:02 pm
crsp
Bullish Trendline Has Never Failed Crispr Therapeutics Stock [Yahoo! Finance]
Low
Report
Bullish Trendline Has Never Failed Crispr Therapeutics Stock [Yahoo! Finance]
4/17
10:28 am
crsp
Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? [Yahoo! Finance]
Low
Report
Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? [Yahoo! Finance]
4/16
07:22 pm
crsp
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know [Yahoo! Finance]
4/16
03:19 pm
crsp
bluebird (BLUE) Underperforms Industry YTD Amid Challenges [Yahoo! Finance]
Low
Report
bluebird (BLUE) Underperforms Industry YTD Amid Challenges [Yahoo! Finance]
4/15
08:30 am
crsp
CRISPR Therapeutics' (NASDAQ:CRSP) investors will be pleased with their favorable 63% return over the last five years [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics' (NASDAQ:CRSP) investors will be pleased with their favorable 63% return over the last five years [Yahoo! Finance]
4/13
08:54 am
crsp
3 Magnificent Stocks That Could Double or More by 2030 [Yahoo! Finance]
Medium
Report
3 Magnificent Stocks That Could Double or More by 2030 [Yahoo! Finance]
4/11
10:49 am
crsp
Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer [Yahoo! Finance]
Low
Report
Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer [Yahoo! Finance]
4/11
08:06 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
4/9
08:12 pm
crsp
CRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]
4/9
10:19 am
crsp
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics [Yahoo! Finance]
Low
Report
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics [Yahoo! Finance]
4/4
07:37 pm
crsp
CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know [Yahoo! Finance]
4/3
08:24 am
crsp
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Low
Report
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/3
08:00 am
crsp
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
Low
Report
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
4/2
01:02 pm
crsp
Vertex (VRTX) Moves Kidney Disease Drug to Phase 3 Development [Yahoo! Finance]
Low
Report
Vertex (VRTX) Moves Kidney Disease Drug to Phase 3 Development [Yahoo! Finance]
4/1
08:19 am
crsp
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting [Yahoo! Finance]
Low
Report
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting [Yahoo! Finance]
4/1
08:00 am
crsp
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Medium
Report
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
3/30
06:55 am
crsp
3 Unstoppable Stocks to Buy Hand Over Fist in April [Yahoo! Finance]
Low
Report
3 Unstoppable Stocks to Buy Hand Over Fist in April [Yahoo! Finance]
3/30
03:20 am
crsp
Crispr Therapeutics: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plans [Seeking Alpha]
Low
Report
Crispr Therapeutics: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plans [Seeking Alpha]
3/26
11:47 am
crsp
Biotech Roundtable: Is CRISPR all it's cracked up to be? [Seeking Alpha]
Low
Report
Biotech Roundtable: Is CRISPR all it's cracked up to be? [Seeking Alpha]
3/26
02:44 am
crsp
Crispr Therapeutics: CASGEVY Commercial Launch Is Taking Shape [Seeking Alpha]
Low
Report
Crispr Therapeutics: CASGEVY Commercial Launch Is Taking Shape [Seeking Alpha]
3/25
07:53 pm
crsp
CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know [Yahoo! Finance]
Low
Report
CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know [Yahoo! Finance]
3/25
05:31 am
crsp
ARKG: Massive Potential, But Not Worth The Risk Yet For These 3 Reasons [Seeking Alpha]
Low
Report
ARKG: Massive Potential, But Not Worth The Risk Yet For These 3 Reasons [Seeking Alpha]
3/22
04:01 pm
crsp
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment [Seeking Alpha]
Low
Report
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment [Seeking Alpha]